First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
about
Teratogenic mechanisms of medical drugsAntibiotics and oral contraceptive failure - a case-crossover studyReproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability?The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approachAntidepressants, anxiolytics, and hypnotics in pregnancy and lactationBipolar disorder in womenDrugs associated with teratogenic mechanisms. Part II: a literature review of the evidence on human risksModulation of serotonin transporter function during fetal development causes dilated heart cardiomyopathy and lifelong behavioral abnormalitiesAntidepressant use in pregnancy: a critical review focused on risks and controversiesThe effects of periconceptional risk factor exposure and micronutrient supplementation on birth defects in Shaanxi Province in Western ChinaUse of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and SwedenPrenatal antidepressant exposure: clinical and preclinical findings.Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data.Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports.Application of data screening to drug exposure in large risk factor studies of birth defects.Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.Continuing medical education: SSRIs and pregnancy.FDA pregnancy risk categories and the CPS: do they help or are they a hindrance?Serotonin transport and metabolism in the mammary gland modulates secretory activation and involution.Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapyPrenatal exposure to serotonin reuptake inhibitors: a case reportAntidepressant use in pregnancy and the risk of cardiac defectsSelective serotonin reuptake inhibitor exposure during early pregnancy and the risk of birth defects.National trends in antidepressant medication treatment among publicly insured pregnant womenReturning to tricyclic antidepressants for depression during childbearing: clinical and dosing challenges.Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study.Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Medication use in pregnancy in relation to the risk of isolated clubfoot in offspringAntidepressant use in pregnant and postpartum womenAssessment of antihistamine use in early pregnancy and birth defectsMaternal genitourinary infections and the risk of gastroschisis.Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysisBirth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C.New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum.Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development.Treatment of nonpsychotic major depression during pregnancy: patient safety and challengesThe Nordic health registers - an important source when evaluating the safety of antidepressants during pregnancy.Pharmacological treatment of unipolar depression during pregnancy and breast-feeding--a clinical overview.
P2860
Q22337136-B919E308-D60F-4C03-B434-EF1B8D992673Q24596642-E70EFEDC-35A8-4525-9078-6FED071B3084Q24650090-38CCC1F9-52DB-4499-AC9E-3EB65863D108Q26741187-029D0A24-FD3E-4A75-83C2-1E418CB28A16Q26774013-7C98F384-8499-4BC4-8B01-FC4AA3551E41Q26795384-A53BBBEF-7BC2-4096-94B8-2DB655ACBA0FQ26795404-3628690F-845C-4805-B0A0-A6A331D38516Q26991704-877B677A-E167-4477-A42C-EA98EAED0D00Q27300825-50BD2E66-305E-4A2B-8BFF-C86C4DEF2E8BQ28281407-7AA0FBF5-1A84-417D-B02C-1AD92531994FQ28484666-F33CE60A-5C51-4FE1-92A3-40E2E1342447Q28551620-3418CDE5-B80A-4206-9DCF-D3C5F4D964A3Q30415540-C620FD74-FFAA-48AC-9057-57A229C80731Q30459493-A9E6534B-F34C-403A-82B2-E8BC73BE4FC2Q30855293-B8F50699-900E-4CFC-AABE-732D5AFD3906Q30979346-B91CD9DF-6BB5-4CE5-9911-E363077152D5Q30986274-5625B273-DACF-4DA8-A672-C3E53FD16FFFQ33521786-8FFD0ED9-4B39-42F9-84C0-4F66061FD9DDQ33671166-C119406F-B13E-4381-8367-795948DD057BQ33724195-04BEA5A5-1964-4A5A-AA9D-25226D8394DFQ33736087-543CC228-70E6-4708-A18A-B283E0E9EF1EQ33745085-D80B2D64-ED01-4DC2-8755-8AFE4BF69D36Q33763631-B8E85043-6491-4C0D-9288-A0108571A7FBQ33775616-C22A7CAC-9551-491B-8EFC-CC789FF31C2FQ33801507-7B758BE7-89AA-49ED-A8DA-21824F4763FEQ33830556-59A853B3-E7FC-49EE-A087-17B73D01006AQ33976001-CCE5C93A-3F36-4547-9684-BA8D2453F4E4Q34018881-718254FF-9C97-4777-A408-D8F69A096B27Q34047430-FF5962C3-EDE9-4E41-809C-5ECFCC3D03C4Q34048103-034CCDEB-7E52-4934-9CA4-E8522D04F303Q34068023-AE21CC63-BBEB-46E1-8EC6-C1440D300055Q34075092-1034ED7C-C525-462A-848F-EBD32E3BE66DQ34083074-CF5EC095-BCCB-45C5-B484-D9745C018942Q34144128-2C064140-0807-44DA-A36F-332888615774Q34170220-4398B5FD-9A56-4913-BECA-20B04E8E8B3FQ34177689-3B2FA81D-DDB6-4F60-86A0-260F4CB435D7Q34178991-D9E45AD1-38B3-4491-B7BD-2FC394B853B3Q34237681-72F0C13E-EFC9-43F6-B7B2-53D0BA4021B5Q34240630-ADC755BA-532E-48DE-B6F0-6F415690237EQ34250131-0EA0ABC0-9DF4-4C4D-932E-CCB95FB6A485
P2860
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
First-trimester use of selecti ...... and the risk of birth defects.
@ast
First-trimester use of selecti ...... and the risk of birth defects.
@en
First-trimester use of selecti ...... and the risk of birth defects.
@nl
type
label
First-trimester use of selecti ...... and the risk of birth defects.
@ast
First-trimester use of selecti ...... and the risk of birth defects.
@en
First-trimester use of selecti ...... and the risk of birth defects.
@nl
prefLabel
First-trimester use of selecti ...... and the risk of birth defects.
@ast
First-trimester use of selecti ...... and the risk of birth defects.
@en
First-trimester use of selecti ...... and the risk of birth defects.
@nl
P50
P356
P1476
First-trimester use of selecti ...... and the risk of birth defects.
@en
P2093
Angela E Lin
Sonia Hernández-Díaz
P304
P356
10.1056/NEJMOA067407
P407
P577
2007-06-01T00:00:00Z